Huada Yixue is a department of Medical Laboratory Science, Clinical Immunology, Serology.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 29, 2018
WeGene
|
Series B | ¥20M | Biotechnology | — |
Sep 19, 2014
Synbio Technologies
|
Series A | ¥10M | Biotechnology | Yes |
Huada Yixue has had 1 exits. Huada Yixue most notable exits include Synbio Technologies
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 9, 2017 | Synbio Technologies | IPO | Biotechnology | Detail |
Huada Yixue has acquired 1 organizations. Their most recent acquisition was Qinglan Biotech on Jul 20, 2018. They acquired Qinglan Biotech for ¥50M.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Jul 20, 2018
Qinglan Biotech
|
Biotechnology | acquisition | ¥ 50M | Detail |